Efficacy and Safety of Semaglutide Injection vs Ozempic® in Patients With Type 2 Diabetes

NCT06739044 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

494

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Ozempic®
DRUG: HDG1901

Sponsor

Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.